John L. Brottem Insider Trading Activity
Every SEC Form 4 transaction reported by John L. Brottem, sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is John L. Brottem buying or selling?
John L. Brottem reported 1 open-market buys ($67.5K) and 53 sells ($4.7M) across 54 Form 4 filings at 1 company — a net selling position of $4.6M.
Source: SEC EDGAR Form 4
What stands out
- All 54 of John L. Brottem's Form 4 filings are for one company, Outset Medical, Inc. (OM).
- The most recent Form 4 was accepted on Aug 18, 2026 (2 months ago).
- In the last 12 months: no open-market purchases and 6 sales ($87.2K).
- The largest open-market sale in the last 12 months was $53.6K of Outset Medical, Inc. (OM) on Jan 22, 2026. SEC ↗
Key Statistics (as of Aug 18, 2026)
Insider sentiment
Net sellingNet insider flow of $4.6M in net selling, filed between Sep 18, 2020 – Aug 18, 2026.
Companies John L. Brottem files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | OMOutset Medical, Inc. | 54 |
Recent John L. Brottem transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | OM | General Counsel | Sale | 2.6K | $11.6K | SEC ↗ |
| May 20, 2026 | OM | General Counsel | Sale | 2.6K | $9.8K | SEC ↗ |
| Feb 20, 2026 | OM | General Counsel | Sale | 2.8K | $9.5K | SEC ↗ |
| Jan 22, 2026 | OM | General Counsel | Sale | 10.5K | $53.6K | SEC ↗ |
| Jan 8, 2026 | OM | General Counsel | Sale | 224 | $956.48 | SEC ↗ |
| Nov 18, 2025 | OM | General Counsel | Sale | 388 | $1.8K | SEC ↗ |
| Aug 18, 2025 | OM | General Counsel | Sale | 383 | $4.9K | SEC ↗ |
| May 16, 2025 | OM | General Counsel | Sale | 396 | $7.1K | SEC ↗ |
| Feb 19, 2025 | OM | General Counsel | Sale | 6.1K | $5.5K | SEC ↗ |
| Jan 22, 2025 | OM | General Counsel | Sale | 32.9K | $26.3K | SEC ↗ |
| Jan 13, 2025 | OM | General Counsel | Sale | 20.5K | $16.6K | SEC ↗ |
| Jan 8, 2025 | OM | General Counsel | Sale | 1.6K | $2.0K | SEC ↗ |
| Nov 18, 2024 | OM | General Counsel | Sale | 3.2K | $2.6K | SEC ↗ |
| Aug 15, 2024 | OM | General Counsel | Sale | 3.0K | $2.5K | SEC ↗ |
| Jun 14, 2024 | OM | General Counsel | Sale | 10.6K | $50.5K | SEC ↗ |
| May 17, 2024 | OM | General Counsel | Sale | 3.0K | $10.5K | SEC ↗ |
| Feb 16, 2024 | OM | General Counsel | Sale | 3.3K | $11.9K | SEC ↗ |
| Jan 18, 2024 | OM | General Counsel | Sale | 1.5K | $6.3K | SEC ↗ |
| Jan 9, 2024 | OM | General Counsel | Sale | 7.3K | $40.3K | SEC ↗ |
| Nov 17, 2023 | OM | General Counsel | Sale | 1.4K | $6.8K | SEC ↗ |
| Aug 17, 2023 | OM | General Counsel | Sale | 1.4K | $20.6K | SEC ↗ |
| Jul 20, 2023 | OM | General Counsel | Sale | 1.4K | $28.3K | SEC ↗ |
| Jun 21, 2023 | OM | General Counsel | Sale | 1.4K | $31.1K | SEC ↗ |
| May 17, 2023 | OM | General Counsel | Sale | 4.1K | $81.4K | SEC ↗ |
| May 5, 2023 | OM | General Counsel | Sale | 1.4K | $28.3K | SEC ↗ |
Showing the 25 most recent filings of 54. Screen every filing.
John L. Brottem insider trading FAQ
Is John L. Brottem buying or selling?
Across 54 SEC Form 4 filings, John L. Brottem reported 1 open-market purchases totaling $67.5K and 53 sales totaling $4.7M — a net selling position of $4.6M.
Which companies does John L. Brottem file Form 4s for?
John L. Brottem has reported insider transactions at 1 company, most often Outset Medical, Inc. (OM).
How far back does John L. Brottem's filing history go?
Trabud holds John L. Brottem's SEC Form 4 filings from Sep 18, 2020 – Aug 18, 2026, sourced directly from SEC EDGAR.
Where does Trabud get John L. Brottem's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track John L. Brottem and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener